<DOC>
	<DOCNO>NCT03019458</DOCNO>
	<brief_summary>To see whether MINGO , food supplement , able lessen drastic weight loss see among X-linked Dystonia Parkinsonism patient .</brief_summary>
	<brief_title>MINGO Supplemental Trial X-linked Dystonia-Parkinsonism Patients</brief_title>
	<detailed_description>X-linked dystonia parkinsonism ( XDP , formerly know DYT3 ) occur primarily Filipino male characterize neurodegenerative dystonia parkinsonism . It currently recognize wide phenotypic variability relate age onset , location disease onset rate severity/disease progression . Most patient begin focal dystonia generalizes development parkinsonism later disease course . XDP patient suffer severe nutritional loss due symptom dysphagia , loss appetite , consistently high metabolic requirement bring movement disorder . Approximately 79 % patient XDP experience rapid weight loss since onset disease . It aim researcher assess clinical usefulness add nutritional supplement daily dietary need patient . MINGO supplement consist local ingredient moringa , rice mung bean , add type edible paste , food , liquid . Mingo gain popularity emergency food disaster relief operation due ease preparation , high nutritional value relatively low price . For last two year , also use agent nutritional build malnourish population child . This study provide valuable information whether patient XDP increase weight consume MINGO , lead improvement patient ' medical care wellbeing .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Dystonia Musculorum Deformans</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<criteria>Subject age 18 Positive Diagnosis XDP movement disorder specialist/fellow Subject yes response `` supportive home environment '' patient 's recent `` doctor monthly report '' Subject easily accessible passable road pubic transportation Subjects extreme movement prevent staff perform BMI MUAC measurement Subjects abnormal metabolic lab prior start study Subjects take pharmacological medicinal supplement may effect weight Subjects hospitalize within last 2 week start trial Subjects Nasogastric tube Gtube Subjects history disease effect weight ( eg : hypo/hyperthyroidism )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>prospective randomize trial</keyword>
</DOC>